1322 related articles for article (PubMed ID: 21143139)
1. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
2. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
Kaushal V; Koeberle PD; Wang Y; Schlichter LC
J Neurosci; 2007 Jan; 27(1):234-44. PubMed ID: 17202491
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
Illes P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the intracellular ion channel CLIC1 in microglia-mediated beta-amyloid-induced neurotoxicity.
Novarino G; Fabrizi C; Tonini R; Denti MA; Malchiodi-Albedi F; Lauro GM; Sacchetti B; Paradisi S; Ferroni A; Curmi PM; Breit SN; Mazzanti M
J Neurosci; 2004 Jun; 24(23):5322-30. PubMed ID: 15190104
[TBL] [Abstract][Full Text] [Related]
5. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
6. Intracellular ion channel CLIC1: involvement in microglia-mediated β-amyloid peptide(1-42) neurotoxicity.
Skaper SD; Facci L; Giusti P
Neurochem Res; 2013 Sep; 38(9):1801-8. PubMed ID: 23743620
[TBL] [Abstract][Full Text] [Related]
7. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole.
Liu BS; Ferreira R; Lively S; Schlichter LC
J Neuroimmune Pharmacol; 2013 Mar; 8(1):227-37. PubMed ID: 22527636
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies.
Gupta N; Shyamasundar S; Patnala R; Karthikeyan A; Arumugam TV; Ling EA; Dheen ST
Expert Opin Ther Targets; 2018 Sep; 22(9):765-781. PubMed ID: 30138572
[TBL] [Abstract][Full Text] [Related]
9. Ca
Cocozza G; di Castro MA; Carbonari L; Grimaldi A; Antonangeli F; Garofalo S; Porzia A; Madonna M; Mainiero F; Santoni A; Grassi F; Wulff H; D'Alessandro G; Limatola C
Brain Behav Immun; 2018 Oct; 73():584-595. PubMed ID: 29981425
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells.
Ferreira R; Schlichter LC
PLoS One; 2013; 8(4):e62345. PubMed ID: 23620825
[TBL] [Abstract][Full Text] [Related]
11. Ion channels and transporters in microglial function in physiology and brain diseases.
Luo L; Song S; Ezenwukwa CC; Jalali S; Sun B; Sun D
Neurochem Int; 2021 Jan; 142():104925. PubMed ID: 33248207
[TBL] [Abstract][Full Text] [Related]
12. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.
Takeuchi H; Mizoguchi H; Doi Y; Jin S; Noda M; Liang J; Li H; Zhou Y; Mori R; Yasuoka S; Li E; Parajuli B; Kawanokuchi J; Sonobe Y; Sato J; Yamanaka K; Sobue G; Mizuno T; Suzumura A
PLoS One; 2011; 6(6):e21108. PubMed ID: 21712989
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of microglia neuroprotection: Involvement of P2X7, TNFα, and valproic acid.
Masuch A; Shieh CH; van Rooijen N; van Calker D; Biber K
Glia; 2016 Jan; 64(1):76-89. PubMed ID: 26295445
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia.
Schilling T; Eder C
J Cell Physiol; 2011 Dec; 226(12):3295-302. PubMed ID: 21321937
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury.
Anrather J; Gallo EF; Kawano T; Orio M; Abe T; Gooden C; Zhou P; Iadecola C
PLoS One; 2011; 6(10):e25916. PubMed ID: 22022466
[TBL] [Abstract][Full Text] [Related]
17. KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?
Ferreira R; Wong R; Schlichter LC
Front Immunol; 2015; 6():153. PubMed ID: 25904916
[TBL] [Abstract][Full Text] [Related]
18. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
19. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
Yiangou Y; Facer P; Durrenberger P; Chessell IP; Naylor A; Bountra C; Banati RR; Anand P
BMC Neurol; 2006 Mar; 6():12. PubMed ID: 16512913
[TBL] [Abstract][Full Text] [Related]
20. IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia.
Ferreira R; Lively S; Schlichter LC
Front Cell Neurosci; 2014; 8():183. PubMed ID: 25071444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
